Vidaza and haemoglobin decreased Patient Reports February 11, 2012

Vidaza Side Effects Report #5827995-3
Vidaza side effect was reported by a Consumer or non-health professional from UNITED STATES on July 17, 2008. Male patient, 86 years of age, weighting 145.9 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: haemoglobin decreased, intestinal perforation, mental disorder, mood altered. Vidaza dosage: (50 MG/M2, DAILY X 5 DAYS), SUBCUTANEOUS. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5842965-7
Vidaza side effect was reported by a Physician from UNITED STATES on July 29, 2008. Female patient, 82 years of age, weighting 163.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: colitis, dizziness , dyspnoea, haematochezia, haemoglobin decreased. Vidaza dosage: (100 MG/M2, DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with ZOCOR, TOPROL, VITAMIN. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5422042-X
Vidaza side effect was reported by a Physician from UNITED STATES on Aug 03, 2007. Female patient, 80 years of age, weighting 145.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: asthenia, carotid arteriosclerosis, haemoglobin decreased, heart rate irregular, hypotension, iron overload, local swelling, loss of consciousness, pyrexia. Vidaza dosage: 75 MG/M2, INTRAVENOUS. During the same period patient was treated with HYDROCHLOROTHIAZIDE, ENALAPRIL, METOPROLOL TARTRATE, ASPIRIN, DEFERASIROX. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #4884890-4
Vidaza side effect was reported by a Health Professional from UNITED STATES on Jan 02, 2006. Male patient, 80 years of age, weighting 130.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abdominal pain , cardio-respiratory arrest, diarrhoea, haemoglobin decreased, jaundice , neutropenia, pyrexia. Vidaza dosage: 60 MG(M2 (100 MG), SUBCUTANEOUS. During the same period patient was treated with ADVAIR DISKUS, LASIX, NORVASC, PLAVIX, PROTONIX, PREDNISONE, TOPROL, PRAVACHOL. Patient died on 10/31/2005.


Vidaza Side Effects Report #5229612-2
Vidaza side effect was reported by a Physician from UNITED STATES on Jan 18, 2007. Male patient, 79 years of age, weighting 140.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: coma, dialysis , haemoglobin decreased, haemorrhage, hypotension, leukopenia, pneumonia . Vidaza dosage: 75 MG/M2 (130 MG, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with COUMADIN, LIPITOR, DIGITEX, ATACAND, ARANESP. Patient was hospitalized. Patient died on 02/16/2006.

Vidaza Side Effects Report #4949686-3
Vidaza side effect was reported by a Health Professional from UNITED STATES on Mar 03, 2006. Male patient, 79 years of age, weighting 188.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: asthenia, blood pressure decreased, dyspnoea, haemoglobin decreased, pneumonia , tremor, white blood cell count decreased. Vidaza dosage: 50 MG/M2 (100 MG, DAILY), SUBCUTANEOUS. During the same period patient was treated with PREDNISONE, FUROSEMIDE, VALSARTAN, LANSOPRAZOLE. Patient was hospitalized. Patient died on 01/25/2006.

Vidaza Side Effects Report #5486003-7
Vidaza side effect was reported by a Physician from ITALY on Sept 28, 2007. Male patient, 72 years of age, weighting 158.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, aspergillosis, blood pressure increased, cytomegalovirus infection , epstein-barr virus infection, haemoglobin decreased, platelet count decreased, pneumocystis jiroveci pneumonia, urinary retention. Vidaza dosage: (140 MG, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with VALPROIC ACID, BACTRIM, PREDNISONE, RABEPRAZOLE, FOSFAMICINA, TROMETAMOLO, CARVEDILOLO. Patient was hospitalized. Patient died on 08/24/2007.

Vidaza Side Effects Report #4634696-6
Vidaza side effect was reported by a Physician from on Mar 31, 2005. Male patient, 72 years of age, weighting 183.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abdominal pain , acute abdomen, adhesion , cardiac output decreased, computerised tomogram abnormal, enteritis, gastrointestinal disorder, haemoglobin decreased, intestinal obstruction. Vidaza dosage: 150 MG (75 MG/M2, DAILY X 5 DAYS), SUBCUTANEOUS. During the same period patient was treated with THALOMID. Patient died on 03/30/2005.

Vidaza Side Effects Report #4557600-8
Vidaza side effect was reported by a Physician from on Jan 10, 2005. Male patient, 64 years of age, weighting 273.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, chills, disseminated intravascular coagulation, flank pain, gastrointestinal haemorrhage, haematuria, haemodialysis, haemoglobin decreased, hyperbilirubinaemia. Vidaza dosage: 75 MG/M2 (175 MG, DAILY), SUBCUTANEOUS. During the same period patient was treated with MIRAPEX, CLONAZEPAM, COREG, ALTACE, ASPIRIN, ADVAIR, MAXAIR, HYDROCHLOROTHIAZIDE. Patient died on 01/07/2005.


Vidaza Side Effects Report #4638334-8
Vidaza side effect was reported by a Physician from on Apr 04, 2005. Female patient was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, cardiac failure, cerebrovascular accident, condition aggravated, haemoglobin decreased, neutropenia, platelet count decreased, platelet count increased, pneumonia . Vidaza dosage: 150 MG ( 7 DAYS/MONTH), SUBCUTANEOUS. During the same period patient was treated with OFLOCET, AMPICILLIN. Patient was hospitalized. Patient died on 04/01/2005.